Sulforaphane: History and Discovery

Most antioxidants people take were known long before anyone understood them. Sulforaphane is the opposite: it was made in a chemistry lab before it was ever found in food, studied first as an antibiotic, and only decades later traced back to the broccoli on the dinner plate. Its story runs from a 1948 synthesis in Switzerland, through a 1959 isolation from a roadside weed in Czechoslovakia, to the moment in 1992 when a Johns Hopkins team hunting for the most potent cancer-protective compound in vegetables pulled it out of broccoli — and then, in 1997, found it most concentrated of all in tiny three-day-old broccoli sprouts. This page tells that documented story, naming the real chemists and the real dates. Where the early record is thin or the precise wording of a claim is uncertain, it says so plainly rather than guessing.

Table of Contents

  1. A Molecule Hidden in the Cabbage Family
  2. First Made in the Lab: Schmid and Karrer, 1948
  3. Found in Nature: The Hoary-Cress Antibiotic, 1959
  4. Where the Name “Sulforaphane” Comes From
  5. The Broccoli Breakthrough: Talalay's Lab, 1992
  6. Broccoli Sprouts: The 1997 Discovery
  7. Decoding the Mechanism: Keap1 and Nrf2
  8. From Bench to Clinic: The Modern Era
  9. Research Papers and References
  10. Connections
  11. Featured Videos

A Molecule Hidden in the Cabbage Family

Long before sulforaphane had a name, people had been eating the plants that make it. Broccoli, cabbage, kale, cauliflower, radish, watercress, and the rest of the cruciferous (mustard) family have been cultivated and eaten for thousands of years, and the sharp, slightly bitter, sometimes peppery bite of these vegetables comes from a family of sulfur compounds the plants use as a chemical defense. That pungency — the same quality that gives mustard, horseradish, and wasabi their kick — is the taste of isothiocyanates, the chemical class to which sulforaphane belongs.

It is worth being clear about what that long culinary history does and does not tell us. People ate cruciferous vegetables for nourishment and flavor; they did not know that a specific molecule was forming when they chopped or chewed them, and there is no traditional record of anyone isolating or naming sulforaphane in antiquity. Unlike a herb such as ashwagandha, whose recorded use stretches back through ancient medical texts, sulforaphane has no folklore of its own. Its documented history is almost entirely a scientific one, and a surprisingly recent one: nearly everything we know about it was worked out in the second half of the twentieth century and the first quarter of the twenty-first.

That is what makes its story unusual among the compounds covered on this site. We can name the chemists who first made it, the weed it was first pulled out of, the laboratory that recognized what it could do, and the years each step happened. The sections that follow do exactly that.

Back to Table of Contents

First Made in the Lab: Schmid and Karrer, 1948

Sulforaphane's recorded history begins not in a kitchen or a field but in a chemistry laboratory. The compound was first chemically synthesized in 1948 by Hermann Schmid and Paul Karrer, working in Switzerland and publishing in the journal Helvetica Chimica Acta. Paul Karrer was one of the most distinguished organic chemists of the era — he had shared the 1937 Nobel Prize in Chemistry for his work on the structure of carotenoids and vitamins — and the synthesis of sulforaphane was part of his group's broader study of sulfur-containing natural-product chemistry.

What Schmid and Karrer made was the molecule now formally named 1-isothiocyanato-4-(methylsulfinyl)butane. Their laboratory synthesis produced it as a racemic mixture — that is, a roughly equal blend of two mirror-image forms — whereas the version that nature builds inside cruciferous plants is a single specific form. That distinction would matter later for chemists trying to match synthetic material to the natural product, but the central point for this history is simpler: the structure and the means of making sulforaphane were in the chemical literature by the late 1940s, years before anyone connected it to diet or health.

This is the reverse of the usual pattern for a dietary compound. More often a plant is used first, the active molecule is isolated from it later, and synthesis comes last. With sulforaphane, the pure synthetic molecule came first and the food connection came decades afterward — one of the genuinely distinctive features of its story.

Back to Table of Contents

Found in Nature: The Hoary-Cress Antibiotic, 1959

The next milestone moved sulforaphane from the synthesis bench to the natural world — and, tellingly, it arrived through the search for an antibiotic rather than an antioxidant. In 1959, the Czech chemist Z. Procházka reported isolating sulforaphane from a wild cruciferous plant on the basis of its antibacterial activity, publishing in the Collection of Czechoslovak Chemical Communications. The source plant was hoary cress — known botanically as Cardaria draba (also written Lepidium draba), a hardy, fast-spreading weed of roadsides and disturbed ground.

The detail that sulforaphane was first isolated from nature because it killed bacteria is easy to overlook, but it foreshadows one of the compound's most distinctive modern uses. Decades later, researchers would show that sulforaphane is active against Helicobacter pylori, the stomach bacterium behind most peptic ulcers — an echo of the very property that brought it to scientific attention in 1959. The plant's pungent, mustard-like compounds had long been understood, in a general way, to deter pests and microbes; the 1959 work pinned that activity to a specific, named molecule.

One honest caveat about this period of the history: these are old papers, written largely in the chemical idiom of their day and not always easy to access now, and different modern reviews summarize the early dates and attributions with slightly different emphasis. What the sources consistently agree on — and what this page therefore states — is that sulforaphane was synthesized around the late 1940s and isolated from a natural cruciferous source (hoary cress) on the basis of its antimicrobial activity around 1959, well before its cancer-protective role was recognized. Finer bibliographic particulars beyond that are reported by the modern review literature cited below rather than re-derived here.

Back to Table of Contents

Where the Name “Sulforaphane” Comes From

The word sulforaphane itself carries a small piece of the chemistry in its spelling. According to Merriam-Webster, the name is built from sulfo- (pointing to the molecule's sulfur atoms) plus -raphen — the dictionary tracing it to sulforaphen, a chemically related substance, and noting that -raphen is perhaps an alteration of raphanin, a name derived in turn from the New Latin genus name Raphanus, the cruciferous genus that includes the radish. In other words, the name roughly reads as “the sulfur compound of the radish family.” The closely related compound sulforaphene, found notably in radish, sits right beside it in both name and structure.

This etymology is a neat fossil of how the compound was first encountered: among the sharp-tasting sulfur chemicals of the mustard-and-radish clan, long before broccoli became its public face. It is a reminder that, chemically, sulforaphane belongs to the whole cruciferous family, not to broccoli alone — broccoli simply turned out to be an unusually rich source of its precursor.

Merriam-Webster dates the first known use of the English word “sulforaphane” to 1992 — the same year as the broccoli breakthrough described next. That timing is not a coincidence: although the molecule had existed in the chemical literature since 1948 and in nature far longer, it was the 1992 work that brought the term into wide scientific and, eventually, popular use.

Back to Table of Contents

The Broccoli Breakthrough: Talalay's Lab, 1992

The turning point in sulforaphane's history — the moment it changed from an obscure mustard-oil chemical into one of the most studied compounds in nutrition — came in 1992 at the Johns Hopkins University School of Medicine. The pharmacologist Paul Talalay had spent years pursuing a deceptively simple question: which foods most strongly switch on the body's own protective “phase II” detoxification enzymes, the enzymes that neutralize carcinogens before they can damage DNA?

To answer it, Talalay's group did not start from a molecule and look for its effects. They did the reverse. They used a laboratory readout — the induction of a phase II enzyme called quinone reductase (NQO1) in cultured cells — as a kind of detector, then screened vegetable extracts to see which lit it up most strongly. Broccoli came out as one of the most powerful inducers, so the team set about isolating the single compound responsible. Guided step by step by that enzyme-induction assay, Yuesheng Zhang, Paul Talalay, Cho-Gyung (C. G.) Cho, and Gary H. Posner purified the active principle from broccoli and identified it as sulforaphane. Their paper, “A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure,” appeared in the Proceedings of the National Academy of Sciences in 1992.

Two things make this a genuine landmark. First, it was the moment the 1948 laboratory molecule and the everyday vegetable were finally shown to be the same thing — sulforaphane in broccoli, doing something biologically important. Second, it framed sulforaphane in a way that has shaped every study since: not as a substance that mops up free radicals one at a time, but as an inducer that switches on a whole battery of the body's own protective enzymes. That “indirect antioxidant” framing — explained in full on the main Sulforaphane page — originated with Talalay's laboratory and is the conceptual heart of the field.

Back to Table of Contents

Broccoli Sprouts: The 1997 Discovery

If 1992 put sulforaphane on the map, 1997 is the year that gave the world broccoli sprouts. Building directly on the earlier work, Jed W. Fahey, Yuesheng Zhang, and Paul Talalay — again at Johns Hopkins — published “Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens” in the Proceedings of the National Academy of Sciences.

Their central finding was striking and is the basis of the broccoli-sprout phenomenon that followed. Very young sprouts — broccoli just three days old — contained the sulforaphane precursor (the glucosinolate glucoraphanin) at concentrations roughly 10 to 100 times higher than mature broccoli heads, weight for weight. A small handful of sprouts could therefore carry as much sulforaphane potential as a far larger serving of grown broccoli. The young plant front-loads its chemical defenses before it has any physical ones, then dilutes the precursor as it grows.

The practical consequences were immediate. A cheap, fast-growing, intensely concentrated dietary source meant researchers could run human studies with a realistic food rather than only with chemicals in a dish — and it meant ordinary people could grow a meaningful source of sulforaphane in a jar on the kitchen counter in a few days. Much of the clinical research that followed, from detoxification trials to the autism and diabetes studies, used standardized broccoli-sprout preparations precisely because of what Fahey, Zhang, and Talalay reported in 1997. The dietary and food-chemistry details — including why the enzyme myrosinase must be present for the precursor to convert — are covered on the main Sulforaphane page and the Broccoli food page.

Back to Table of Contents

Decoding the Mechanism: Keap1 and Nrf2

Knowing that sulforaphane switched on protective enzymes was one thing; understanding how it threw the switch took the field into the 2000s. The answer turned out to involve two proteins with awkward names: Nrf2, a master regulator that turns on a large family of antioxidant and detoxification genes, and Keap1, the partner protein that normally keeps Nrf2 switched off by continually marking it for destruction.

A pivotal step came in 2002, when Albena Dinkova-Kostova, Paul Talalay, and colleagues (a collaboration that included Masayuki Yamamoto's group) published direct evidence in the Proceedings of the National Academy of Sciences that the sensors controlling this whole system are specific reactive sulfur atoms (sulfhydryl/cysteine groups) on Keap1. Sulforaphane, the work showed, reacts with exactly those sensor cysteines; doing so disables Keap1, lets Nrf2 escape and accumulate, and thereby switches on the protective gene program. This explained at the molecular level why a single dose of sulforaphane can produce effects lasting for days — it is not consumed neutralizing a radical, but instead flips a genetic switch that makes the cell manufacture its own defensive enzymes.

This mechanistic picture is what elevated sulforaphane from “a useful compound in broccoli” to a textbook example of an indirect, catalytic antioxidant — and it is why the same Keap1–Nrf2 pathway is now a major target across cancer prevention, neuroprotection, and metabolic research. The full mechanism, including the downstream enzymes involved, is laid out on the main Sulforaphane page.

Back to Table of Contents

From Bench to Clinic: The Modern Era

From the late 1990s onward, sulforaphane research expanded from cell cultures and animal models into human trials, and the questions shifted from “what is it and how does it work?” to “what can it actually do in people?” The areas that drew the most attention map closely onto the compound's mechanism: detoxification, cancer chemoprevention, brain and metabolic health, and infection.

A clear milestone in the human-evidence story was a large randomized trial reported in 2014 by Patricia Egner, Thomas Kensler, and colleagues — another Johns Hopkins-led effort — conducted in Qidong, China, a region with heavy dietary and airborne carcinogen exposure. Adults who drank a standardized broccoli-sprout beverage showed measurably faster excretion of detoxified benzene and acrolein, direct human evidence that sulforaphane accelerates the elimination of common airborne pollutants by switching on the body's own conjugating enzymes. Other randomized trials over the following years probed sulforaphane-rich broccoli-sprout preparations in autism, type 2 diabetes, and Helicobacter pylori infection — the specifics, with citations, are gathered on the main Sulforaphane page.

Two honest framings belong at the close of this history. First, sulforaphane's trajectory is the opposite of most traditional remedies: the chemistry and the mechanism came first, and the population-scale clinical proof is still being assembled — much of the human evidence consists of promising biomarker and early-phase trials rather than definitive disease-outcome studies. Second, the through-line from a 1948 flask of synthetic isothiocyanate, to a weed studied as an antibiotic in 1959, to a jar of broccoli sprouts on a modern kitchen counter is unbroken and well documented. Following that line carefully — and not overstating where it currently ends — is the whole point of knowing the history.

Back to Table of Contents

Research Papers and References

The list below combines the key primary papers in sulforaphane's history with a modern historical-overview review and curated PubMed topic searches. Author names, titles, and journals are given as plain text; only stable DOI, PMID, or reference links are hyperlinked, and each opens in a new tab. The earliest synthesis and isolation papers (Schmid & Karrer, 1948, in Helvetica Chimica Acta; Procházka, 1959, in the Collection of Czechoslovak Chemical Communications) are named in the article as historical primary sources; their dates and attributions are documented in the modern review literature cited below.

  1. Zhang Y, Talalay P, Cho CG, Posner GH. A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proceedings of the National Academy of Sciences USA. 1992;89(6):2399-2403. — doi:10.1073/pnas.89.6.2399 · PMID: 1549603
  2. Fahey JW, Zhang Y, Talalay P. Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proceedings of the National Academy of Sciences USA. 1997;94(19):10367-10372. — doi:10.1073/pnas.94.19.10367 · PMID: 9294217
  3. Dinkova-Kostova AT, Holtzclaw WD, Cole RN, Itoh K, Wakabayashi N, Katoh Y, Yamamoto M, Talalay P. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proceedings of the National Academy of Sciences USA. 2002;99(18):11908-11913. — doi:10.1073/pnas.172398899 · PMID: 12193649
  4. Zhang Y, Tang L. Discovery and development of sulforaphane as a cancer chemopreventive phytochemical. Acta Pharmacologica Sinica. 2007;28(9):1343-1354. — doi:10.1111/j.1745-7254.2007.00679.x · PMID: 17723168
  5. Egner PA, Chen JG, Kensler TW, et al. Rapid and sustainable detoxication of airborne pollutants by broccoli sprout beverage: results of a randomized clinical trial in China. Cancer Prevention Research. 2014;7(8):813-823. — doi:10.1158/1940-6207.CAPR-14-0103 · PMID: 24913818
  6. Sulforaphane — history and discovery — PubMed: sulforaphane history and discovery
  7. Sulforaphane isolation and phytochemistry — PubMed: sulforaphane isolation and isothiocyanate chemistry

External Authoritative Resources

Back to Table of Contents

Connections

Back to Table of Contents